About Branch Therapeutics
Branch Therapeutics is a private company based in Houston, Texas, incorporated in 2024 in Delaware. It has reported $3,999,994 raised in one offering on Form D since May 2025. Its chief executive is Curtis Thorne.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 30, 2025 | May 23, 2025 | $3,999,994fully sold | 1 | $3.9M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Branch Therapeutics's Form D filed May 23, 2025.